Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2006;98:1506-1513
Published online before print May 18, 2006, doi: 10.1161/01.RES.0000227506.43292.df
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
98/12/1506    most recent
01.RES.0000227506.43292.dfv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carter, S.
Right arrow Articles by Sitsapesan, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carter, S.
Right arrow Articles by Sitsapesan, R.
Related Collections
Right arrow Calcium cycling/excitation-contraction coupling
Right arrow Ion channels/membrane transport
(Circulation Research. 2006;98:1506.)
© 2006 American Heart Association, Inc.


Cellular Biology

Maximum Phosphorylation of the Cardiac Ryanodine Receptor at Serine-2809 by Protein Kinase A Produces Unique Modifications to Channel Gating and Conductance Not Observed at Lower Levels of Phosphorylation

Simon Carter, John Colyer, Rebecca Sitsapesan

From the Department of Pharmacology (S.C., R.S.), University of Bristol; and Institute of Membrane & Systems Biology (J.C.), University of Leeds, UK.

Correspondence to Rebecca Sitsapesan, University of Bristol, Department of Pharmacology, School of Medical Sciences, University Walk, Bristol BS8 1TD, UK. E-mail r.sitsapesan{at}bris.ac.uk

It is suggested that protein kinase A (PKA)-dependent phosphorylation of cardiac ryanodine receptors (RyR2) is linked to the development of heart failure and the generation of fatal cardiac arrhythmias. It is also suggested that RyR2 is phosphorylated to 75% of maximum levels in heart failure resulting in leaky, unregulated channels gating in subconductance states. We now demonstrate that this is unlikely, as RyR2 isolated from nonfailing cardiac muscle is phosphorylated to 75% of maximum at serine-2809, and in this situation, RyR2 displays low open probability (Po) (0.059±0.010 [SEM]; n=30) and normal regulation of gating by Ca2+ and other ligands. However, when serine-2809 is PKA phosphorylated to maximum levels on RyR2, unique changes in channel behavior are observed. The channel displays enhanced single-channel conductance, very long open states causing large increases in Po, and no evidence of subconductance states. Dephosphorylation of channels by protein phosphatase 1 (from 75% to near 0% at serine-2809) also enhances RyR2 channel activity through abbreviation of closed lifetimes. We propose that channels phosphorylated to 75% of maximum at serine-2809 occupy a natural low point in the RyR2 activity landscape. This optimizes channel control, which can be accomplished either by enhanced or decreased phosphorylation, making the channel particularly sensitive to the kinase:phosphatase balance. Pathological situations such as heart failure might upset this balance and thereby permit prolonged stoichiometric phosphorylation of serine-2809, which would be required for dysregulation of SR Ca2+ release.


Key Words: phosphorylation • ryanodine receptor • Ca2+ release • excitation–contraction coupling




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Zhou, Y.-T. Zhao, Y.-B. Guo, S.-M. Xu, S.-H. Bai, E. G. Lakatta, H. Cheng, X.-M. Hao, and S.-Q. Wang
{beta}-Adrenergic signaling accelerates and synchronizes cardiac ryanodine receptor response to a single L-type Ca2+ channel
PNAS, October 20, 2009; 106(42): 18028 - 18033.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. M. Blayney, J.-L. Jones, J. Griffiths, and F. A. Lai
A mechanism of ryanodine receptor modulation by FKBP12/12.6, protein kinase A, and K201
Cardiovasc Res, September 2, 2009; (2009) cvp273v2.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. L. Hamilton and I. I. Serysheva
Ryanodine Receptor Structure: Progress and Challenges
J. Biol. Chem., February 13, 2009; 284(7): 4047 - 4051.
[Full Text] [PDF]


Home page
Circ Arrhythm ElectrophysiolHome page
Y.-H. Yeh, R. Wakili, X.-Y. Qi, D. Chartier, P. Boknik, S. Kaab, U. Ravens, P. Coutu, D. Dobrev, and S. Nattel
Calcium-Handling Abnormalities Underlying Atrial Arrhythmogenesis and Contractile Dysfunction in Dogs With Congestive Heart Failure
Circ Arrhythm Electrophysiol, June 1, 2008; 1(2): 93 - 102.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Zhu, A. A. Gach, G. Liu, X. Xu, C. C. Lim, J. X. Zhang, L. Mao, K. Chuprun, W. J. Koch, R. Liao, et al.
Enhanced calcium cycling and contractile function in transgenic hearts expressing constitutively active G{alpha}o* protein
Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1335 - H1347.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
Y. Ikeda, M. Hoshijima, and K. R. Chien
Toward Biologically Targeted Therapy of Calcium Cycling Defects in Heart Failure
Physiology, February 1, 2008; 23(1): 6 - 16.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. H. George
Sarcoplasmic reticulum Ca2+ leak in heart failure: mere observation or functional relevance?
Cardiovasc Res, January 15, 2008; 77(2): 302 - 314.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. F. James
Inhibition of SR Ca2+ uptake: A novel action of the RyR2-FKBP12.6 antagonist K201
Cardiovasc Res, November 1, 2007; 76(2): 199 - 201.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Xiao, X. Tian, W. Xie, P. P. Jones, S. Cai, X. Wang, D. Jiang, H. Kong, L. Zhang, K. Chen, et al.
Functional Consequence of Protein Kinase A-dependent Phosphorylation of the Cardiac Ryanodine Receptor: SENSITIZATION OF STORE OVERLOAD-INDUCED Ca2+ RELEASE
J. Biol. Chem., October 12, 2007; 282(41): 30256 - 30264.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
N. A. Benkusky, C. S. Weber, J. A. Scherman, E. F. Farrell, T. A. Hacker, M. C. John, P. A. Powers, and H. H. Valdivia
Intact {beta}-Adrenergic Response and Unmodified Progression Toward Heart Failure in Mice With Genetic Ablation of a Major Protein Kinase A Phosphorylation Site in the Cardiac Ryanodine Receptor
Circ. Res., October 12, 2007; 101(8): 819 - 829.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
T. Seidler, G. Hasenfuss, and L. S. Maier
Targeting Altered Calcium Physiology in the Heart: Translational Approaches to Excitation, Contraction, and Transcription
Physiology, October 1, 2007; 22(5): 328 - 334.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
L. Pereira, M. Metrich, M. Fernandez-Velasco, A. Lucas, J. Leroy, R. Perrier, E. Morel, R. Fischmeister, S. Richard, J.-P. Benitah, et al.
The cAMP binding protein Epac modulates Ca2+ sparks by a Ca2+/calmodulin kinase signalling pathway in rat cardiac myocytes
J. Physiol., September 1, 2007; 583(2): 685 - 694.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Kockskamper and B. Pieske
Phosphorylation of the Cardiac Ryanodine Receptor by Ca2+/Calmodulin-Dependent Protein Kinase II: The Dominating Twin of Protein Kinase A?
Circ. Res., August 18, 2006; 99(4): 333 - 335.
[Full Text] [PDF]